{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:58:50Z","timestamp":1778641130378,"version":"3.51.4"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T00:00:00Z","timestamp":1264032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim:\u2002<\/jats:bold> To evaluate the performance of the new International Criteria for Beh\u00e7et\u2019s Disease (ICBD) in Iran. The ICBD was created in 2006 to replace the International Study Group (ISG) criteria (created in 1990). In this study, 14 existing diagnosis\/classification criteria (Curth, Hewitt, Mason and Barnes, Japan original, Hubault and Hamza, O\u2019Duffy, Cheng and Zhang, Dilsen, Japan revised, International Study Group, Iran traditional, Iran Classification Tree, revised Dilsen, Korea), were evaluated and compared to ICBD by calculating their sensitivity, specificity and accuracy.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> All patients from the Beh\u00e7et\u2019s Disease registry (6128) and controls (3400), up to January 2008, entered the study. The diagnosis was clinical and not by any of the above\u2010mentioned criteria. Sensitivity, specificity, accuracy (percent agreement), and 95% confidence interval were calculated. The performance of ICBD and ISG were compared by the McNemar test.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The sensitivity was 98.2% for ICBD and 78.1% for ISG (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001). The specificity was 95.6% for ICBD and 98.4% for ISG (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001). The accuracy was 97.3% for ICBD and 85.5% for ISG (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001).<\/jats:p><jats:p><jats:bold>Discussion:\u2002<\/jats:bold> In Iranian patients, ICBD has 20.1% higher sensitivity and 11.8% higher accuracy than ISG, while the specificity was only 2.8% lower. ICBD was better optimized than ISG (difference between sensitivity and specificity 2.6<jats:italic>% vs<\/jats:italic> 20.3%).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> ICBD has by far better performance than ISG in Iran. The difference is even more prominent in Iranian patients than in the cohort of the international patients upon whom the criteria were created.<\/jats:p>","DOI":"10.1111\/j.1756-185x.2009.01455.x","type":"journal-article","created":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T07:22:02Z","timestamp":1264058522000},"page":"55-60","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Validation of the International Criteria for Beh\u00e7et\u2019s disease (ICBD) in Iran"],"prefix":"10.1111","volume":"13","author":[{"given":"Fereydoun","family":"DAVATCHI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahar","family":"SADEGHI ABDOLLAHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"SHAHRAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdolhadi","family":"NADJI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheyda","family":"CHAMS\u2010DAVATCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hormoz","family":"SHAMS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasim","family":"NADERI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massoomeh","family":"AKHLAGHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahereh","family":"FAEZI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"FARIDAR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,1,28]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1946.01510370063005"},{"key":"e_1_2_6_3_2","first-page":"565","article-title":"Criteres de prevision du syndrome de Behcet","volume":"76","author":"Hewitt J","year":"1969","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.28.2.95"},{"key":"e_1_2_6_5_2","first-page":"901","article-title":"Revision des criteres diagnostiques du syndrome de Behcet","volume":"79","author":"Hewitt J","year":"1971","journal-title":"Presse Med"},{"key":"e_1_2_6_6_2","first-page":"291","article-title":"Behcet\u2019s disease guide to diagnosis of Behcet\u2019s disease (1972)","volume":"18","author":"Behcet\u2019s Disease Research Committee of Japan.","year":"1974","journal-title":"Jpn J Ophthalmol"},{"key":"e_1_2_6_7_2","first-page":"43","volume-title":"L\u2019actualit\u00e9 Rhumatologique","author":"Hubault A","year":"1974"},{"key":"e_1_2_6_8_2","first-page":"2371","article-title":"Crit\u00e8res propos\u00e9s pour le diagnostique de la maladie de Beh\u00e7et et notes therapeutiques","volume":"36","author":"O\u2019Duffy JD","year":"1974","journal-title":"Rev Med"},{"key":"e_1_2_6_9_2","first-page":"15","volume":"19","author":"Cheng","year":"1980","journal-title":"J Int Med"},{"key":"e_1_2_6_10_2","first-page":"177","volume-title":"Recent Advances in Behcet\u2019s Disease","author":"Dilsen N","year":"1986"},{"key":"e_1_2_6_11_2","first-page":"59","article-title":"Recent research into Behcet\u2019s disease in Japan","volume":"10","author":"Mizushima Y","year":"1988","journal-title":"Int J Tiss React"},{"key":"e_1_2_6_12_2","first-page":"1078","article-title":"Criteria for diagnosis of Behcet\u2019s disease","volume":"335","author":"International Study Group for Behcet\u2019s Disease","year":"1990","journal-title":"Lancet"},{"key":"e_1_2_6_13_2","first-page":"225","volume-title":"Behcet\u2019s Disease","author":"Davatchi F","year":"1993"},{"key":"e_1_2_6_14_2","first-page":"245","volume-title":"Behcet\u2019s Disease","author":"Davatchi F","year":"1993"},{"key":"e_1_2_6_15_2","first-page":"101","volume-title":"Behcet\u2019s Disease","author":"Dilsen N","year":"2000"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2003.18.1.88"},{"issue":"34","key":"e_1_2_6_17_2","first-page":"S21","article-title":"Validation of the classification criteria commonly used in Korea and a modified set of preliminary criteria for Behcet\u2019s disease: a multi\u2010center study","volume":"22","author":"Chang HK","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-8077.2006.00207.x"},{"issue":"42","key":"e_1_2_6_19_2","first-page":"S13","article-title":"Evaluation of the international criteria for Behcet\u2019s disease (ICBD)","volume":"24","author":"International Team for the Revision of the International Criteria for Behcet\u2019s Disease","year":"2006","journal-title":"Clinic Exp Rheumatol"},{"issue":"42","key":"e_1_2_6_20_2","first-page":"S14","article-title":"Revision of the international criteria for Behcet\u2019s disease (ICBD)","volume":"24","author":"International Team for the Revision of the International Criteria for Behcet\u2019s Disease","year":"2006","journal-title":"Clinic Exp Rheumatol"},{"key":"e_1_2_6_21_2","volume-title":"Evaluation and Revision of the International Study Group Criteria for Beh\u00e7et\u2019s Disease","author":"Davatchi F","year":"2007"},{"key":"e_1_2_6_22_2","first-page":"1384","article-title":"WHO\u2010ILAR COPCORD Study (Stage 1, urban study) in Iran","volume":"35","author":"Davatchi F","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_6_23_2","volume-title":"Epidemiology, Beyond the Basics","author":"Szklo M","year":"2007"},{"key":"e_1_2_6_24_2","volume-title":"Essential Medical Statistics","author":"Kirshwood BR","year":"2003"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1714"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(03)00177-X"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2291010898"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1756-185X.2009.01455.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1756-185X.2009.01455.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T23:10:19Z","timestamp":1698707419000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1756-185X.2009.01455.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1756-185X.2009.01455.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1756-185x.2009.01455.x","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,28]]},"assertion":[{"value":"2010-01-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}